Crescent Biopharma Inc. Watch

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 69 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential. License and Collaboration Agreement by and Among Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Crescent Biopharma Operating Company, LLC, and Crescent Biopharma, Inc. Dated as of December 2, 2025 [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 63 pages Agreement

from S-1 40 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential. License Agreement

from 8-K 21 pages Registration Rights Agreement

from 8-K 36 pages Securities Purchase Agreement

from 8-K 4 pages Amendment No. 1 to License Agreement

from 10-Q 4 pages Amendment No. 1 to the Biologics Master Services Agreement

from 10-Q 18 pages Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan

from 8-K 12 pages Crescent Biopharma, Inc. Executive Severance Plan

from 8-K 27 pages Agreement

from 8-K 16 pages Crescent Biopharma, Inc. 2025 Employee Stock Purchase Plan

from 8-K 19 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan

from 8-K 10 pages Indemnification Agreement

from S-4/A 36 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential. Amended and Restated Adc Discovery and Option Agreement